QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reinstates-neutral-on-first-wave-biopharma

HC Wainwright & Co. analyst Yi Chen reinstates First Wave BioPharma (NASDAQ:FWBI) with a Neutral.

 roth-mkm-maintains-buy-on-first-wave-biopharma-lowers-price-target-to-36

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy and lowers the price target from $...

 why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

 first-wave-biopharma-completes-merger-deal-with-immunogenx-adding-phase-3-ready-candidate-for-celiac-disease

First Wave BioPharma acquires ImmunogenX, focusing on advancing GI pipeline. James Sapirstein remains Chairman & CEO, with ...

 first-wave-biopharma-inc-to-raise-4m-of-gross-proceeds-in-registered-direct-offering-of-525625-shares-of-common-stock-at-a-price-of-761-per-share

First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharm...

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

 why-resources-connection-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results f...

 whats-going-on-with-first-wave-biopharma-stock

First Wave BioPharma, Inc. (NASDAQ: FWBI) shares are trading higher Wednesday.  What To Know:

 roth-mkm-maintains-buy-on-first-wave-biopharma-adjusts-price-target-to-40

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy, adjusts target to $40 from $11.

 why-sofi-technologies-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods dow...

 why-trinity-place-holdings-shares-are-trading-higher-by-80-here-are-20-stocks-moving-premarket

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mor...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION